The mechanism involved in the loss of tolerance and subsequent development of anti-ADAMTS13 antibodies in patients affected by acquired TTP is not clear, but both genetic and environmental factors have been postulated to contribute to the development of primary iTTP [21]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.